Description

1,7,8-Indolizinetriol, Octahydro-6-(Phenylmethyl)Amino-, 1S-(1.Alpha.,6.Beta.,7.Alpha.,8.Beta.,8A.Beta.)- is a complex, stereochemically defined indolizine derivative that serves as a critical chiral building block and intermediate in advanced organic synthesis. Its value lies in its unique polyhydroxylated structure and defined stereochemistry, which are essential for constructing molecules with specific biological activity. This compound is primarily needed by research institutions and pharmaceutical companies engaged in the development of novel therapeutics, agrochemicals, and specialty fine chemicals.

Application

• Pharmaceutical Intermediate: A key chiral synthon for the research and development of potential new drug candidates, particularly in areas requiring complex polycyclic frameworks.
• Agrochemical Synthesis: Used in the creation of advanced, biologically active molecules for crop protection and pest management solutions.
• Academic & Industrial Research: Serves as a valuable reference standard and starting material for methodological studies in asymmetric synthesis and natural product analog development.
• Fine Chemical Production: Employed in the multi-step synthesis of high-value specialty chemicals, flavors, and fragrances requiring precise stereocontrol.
• Bioconjugate Chemistry: The functional groups present make it a candidate for linking to biomolecules in probe or drug delivery system development.

Basic Information

Product Name	1,7,8-Indolizinetriol, Octahydro-6-(Phenylmethyl)Amino-, 1S-(1.Alpha.,6.Beta.,7.Alpha.,8.Beta.,8A.Beta.)-
CAS No.	156205-85-5
Molecular Formula	C15H23NO3
Molecular Weight	265.35 g/mol
Synonyms	(1S,6R,7S,8R,8aR)-Octahydro-6-(benzylamino)-1,7,8-indolizinetriol; 1S-(1α,6β,7α,8β,8aβ)-Octahydro-6-(phenylmethyl)amino]-1,7,8-indolizinetriol; 6-(Benzylamino)octahydro-1,7,8-indolizinetriol; Indolizinetriol derivative CAS 156205-85-5; Chiral Indolizine Alkaloid Intermediate
EINECS	Contact for details

Quality Control

Our 1,7,8-Indolizinetriol derivative is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity, suitable for demanding research and development applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to cGMP principles where applicable, and specifications can be aligned with client requirements for advanced pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 95.0%
Specific Rotation	Contact for details
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 5.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.